Holy Stone Healthcare Co (ROCO:4194) Net Interest Margin (Bank Only) %

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4194 Holy Stone Healthcare Co Ltd ROCO:4194
45 GF Score
Price NT$6.99
GF Value NT$3.93
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Holy Stone Healthcare Co Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

ROCO:4194
45GF Score
Holy Stone Healthcare Co Ltd ROCO:4194
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Holy Stone Healthcare Co (ROCO:4194) Overvalued in 2026?

Based on GuruFocus' analysis, Holy Stone Healthcare Co stock appears to be overvalued. The current stock price of NT$6.99 is trading 77.9% above its estimated GF Value™ of NT$3.93. GuruFocus considers Holy Stone Healthcare Co to be Significantly Overvalued.

Key valuation signals for ROCO:4194:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: NT$3.93 vs. price of NT$6.99 (77.9% above fair value)
  • GF Score™: 45/100 with 2 warning signs

No single metric tells the full story. See the ROCO:4194 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Holy Stone Healthcare Co Business Description

Address Number 88, Section 1, Neihu Road, 4th Floor, Neihu District, Taipei, TWN, 11493
Holy Stone Healthcare Co Ltd is a Taiwan based company focused on a biopolymer drug delivery platform. It is involved in the development of new drugs and medical devices, especially hyaluronic acid related therapeutic products. The products of the company include RenehaVis, SportVis, TRUD, and GAF.
45GF Score

Get the complete analysis for ROCO:4194

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$6.99
Price
NT$3.93
GF Value